Neurology
The neurology strategy evaluates whether reducing inflammation, improving glucose utilization and supporting neuronal function can translate into improvements in memory, movement or fatigue.
Hepatology
The liver-disease program evaluates whether continuous terlipressin delivery can slow fluid accumulation and reduce the burden of repeated procedures for people with refractory ascites.
People-centered research
Each program begins with a specific patient burden and a testable biological hypothesis. Participation in research is voluntary, and trial eligibility and medical decisions should always be discussed with a qualified healthcare professional.
Development-stage information can change. Investigational candidates are not approved, and safety and efficacy have not been established. Review source documents and current regulatory disclosures.